MktsMarkets

BioCardia, Inc.
NASDAQ: BCDAKey statistics
BCDA News
Stories mentioning BCDA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,235 | 1,128 | 936.00 | 1,368 | 1,530 | 1,415 | 931.00 | 800.00 |
| Sales General & Admin | 1,031 | 885.00 | 552.00 | 683.00 | 1,196 | 906.00 | 825.00 | 852.00 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (2,266) | (2,013) | (1,488) | (2,051) | (2,726) | (2,321) | (1,756) | (1,649) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (2,259) | (1,984) | (1,483) | (2,049) | (2,712) | (2,296) | (1,737) | (1,646) |
| Earnings Per Share (Basic) | (0.21) | (0.30) | (0.24) | (0.40) | (0.59) | (0.84) | (0.61) | (0.88) |
| Earnings Per Share (Diluted) | (0.21) | (0.59) | ||||||
| Weighted Average Shares Outstanding (Basic) | 10,812 | 6,667 | 6,278 | 5,060 | 4,636 | 2,744 | 2,827 | 1,877 |
| Weighted Average Shares Outstanding (Diluted) | 10,812 | 4,636 | ||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BCDA
BioCardia, Inc. (NASDAQ: BCDA) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCDA. It last traded at $0.7400 (Nov 19, 2026, 3:11 PM ET), down 4.5% on the day. That gives BioCardia a market capitalisation of $11.7M.
Over the past 52 weeks BCDA has traded between $0.6600 and $1.80.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.3M |
| Dec 31, 2025 | — | -$2.0M |
| Sep 30, 2025 | — | -$1.5M |
| Jun 30, 2025 | — | -$2.0M |
From BioCardia’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…